FTLFNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
FITLIFE BRANDS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$8.23−0.16 (-1.91%)
Close on Oct 19, 2026
- Market cap
- $81.53M
- P/E (TTM)
- 43.3
- Dividend yield
- –
Share price
−$9.47 (−53.50%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
FITLIFE BRANDS, INC. reported revenue of $101.27M for the twelve months to Jun 30, 2026. Free cash flow was $10.02M.
Revenue
$101.27M
TTM Q2 2026
Operating income
$3.90M
TTM Q2 2026
Free cash flow
$10.02M
TTM Q2 2026
EPS, diluted
$0.19
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $81.53M
- P/E ratio
- 43.3
- Price to sales
- 0.81
- Price to book
- 1.72
- Dividend yield
- –
- Free cash flow yield
- 12.29%
Fundamentals
- Revenue
- $101.27M
- Net income
- $1.92M
- EPS, diluted
- $0.19
- Free cash flow
- $10.02M
- Book value per share
- $4.78
- Diluted shares
- 10M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$101.27M
Gross profit
$12.42M
Operating income
$3.90M
Net income
$1.92M
EPS, diluted
$0.19
Free cash flow
$10.02M
Reported periodTrailing twelve months